UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income from consolidated operations	$ 291,411,199	$ 316,820,194
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	78,808,967	70,887,294
Gain on disposal of assets	(161,501)	(1,279,049)
Loss on disposal of assets	13,243	48,618
Gain on sale of investments and technology investment income	(1,637,823)	(4,736,312)
Loss on sale of investments and technology investment losses	6,630,483	14,839,974
Reserve for credit losses	4,778,334	0
Deferred income taxes	(5,832,023)	(9,970,207)
Stock-based compensation expense related to employee stock options, employee stock purchases and restricted stock	26,596,685	30,936,895
Impairment charge	8,376,148	0
Change in operating assets and liabilities:
Accounts receivable, net	(30,771,806)	(34,528,140)
Inventories	35,148,302	(46,837,992)
Prepaid expenses and other	(6,400,676)	(2,616,370)
Accounts payable	52,627,156	(8,976,998)
Accrued liabilities, excluding dividends declared	2,040,885	19,229,845
Net cash provided by operating activities	461,627,573	343,817,752
Activity in investments:
Sales proceeds	71,903,080	35,059,971
Maturities and calls	1,655,000	10,260,000
Purchases	(16,267,120)	(83,764,695)
Plant and equipment additions	(103,418,837)	(102,966,564)
Proceeds from sale of plant and equipment	259,111	142,400
Acquisition of businesses, net of cash acquired	(156,291,615)	0
Loans to technology investment partners	(14,199,157)	0
Increase in other assets	(925,381)	(5,614,129)
Net cash used for investing activities	(217,284,919)	(146,883,017)
CASH FLOWS USED FOR FINANCING ACTIVITIES:
Issuance of common stock from stock plan transactions	13,338,052	24,024,353
Cash dividends paid	(80,586,484)	(83,145,216)
Repurchases of common stock	(229,023,565)	(184,609,148)
Net cash used for financing activities	(296,271,997)	(243,730,011)
NET DECREASE IN CASH, CASH EQUIVALENTS, and RESTRICTED CASH	(51,929,343)	(46,795,276)
CASH, CASH EQUIVALENTS, and RESTRICTED CASH, beginning of period	233,318,766	226,435,019
CASH, CASH EQUIVALENTS, and RESTRICTED CASH, end of period	181,389,423	179,639,743
Reconciliation of cash, cash equivalents and restricted cash to the Unaudited Condensed Consolidated Balance Sheets:
Cash and cash equivalents	178,589,422
Restricted cash included in Prepaid expenses and other	2,800,001
Total cash, cash equivalents and restricted cash	181,389,423	179,639,743
Non-cash investing and financing activities:
Change in property and equipment in accounts payable and accrued expenses and other current liabilities	$ 12,433,422	$ (4,115,011)

GENTEX CORP 10-Q